https://investor.gm.com/news-releases/news-release-details/gm-continued-gain-us-market-share-and-extended-its-truck
Why Sonnet BioTherapeutics (SONN) Stock Is Nosediving
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 26.18% to $0.50 Wednesday morning after announcing a $2.25 million registered direct offering of 5 million